Prosecution Insights
Last updated: May 29, 2026
Application No. 17/817,602

SYSTEMS AND METHODS FOR KINK DETECTION IN A CANNULA

Non-Final OA §102§103§112
Filed
Aug 04, 2022
Priority
Aug 04, 2021 — provisional 63/229,403
Examiner
PLUMB, NIGEL H
Art Unit
2855
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Cercacor Laboratories Inc.
OA Round
3 (Non-Final)
91%
Grant Probability
Favorable
3-4
OA Rounds
0m
Est. Remaining
92%
With Interview

Examiner Intelligence

Grants 91% — above average
91%
Career Allowance Rate
615 granted / 679 resolved
+22.6% vs TC avg
Minimal +1% lift
Without
With
+1.2%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 1m
Avg Prosecution
25 currently pending
Career history
698
Total Applications
across all art units

Statute-Specific Performance

§101
1.2%
-38.8% vs TC avg
§103
63.0%
+23.0% vs TC avg
§102
19.6%
-20.4% vs TC avg
§112
8.6%
-31.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 679 resolved cases

Office Action

§102 §103 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 04/08/2026 has been entered. Response to Arguments Applicant’s arguments with respect to claim 21 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record or any teaching or matter specifically challenged in the argument. In light of an updated search, the allowance of claims 1-20 and 22 is withdrawn. See new rejection below of the respective claims. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 22 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 22, the claim recites “a kink detection system having a sensor” and then later recites “a sensor configured to measure an extent of deformation of the diaphragm”, however it is unclear if the first introduced is the same sensor being recited later in the claim or two distinct sensors. Therefore, the claim has been rendered indefinite. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1-3, 6-17 and 22 are rejected under 35 U.S.C. 103 as being unpatentable over Flaherty US7887505 in view of Olsen US5935106. Regarding claim 1, Flaherty discloses a disease management device (fluid delivery device-10) comprising: a medical delivery pump (dispensers-40 can be a pump device, Col 8 line 4-27) configured to deliver a medication (Col 5 line 46-61) from a medication pouch (reservoir-30) to a patient via a cannula implanted in a patient (exit port assembly-70 connected to flow path -210 includes a cannula, Col 7 line 32-60); and a kink detection system (flow condition assembly-200) configured to measure an obstruction in the cannula (Col 5 line 37-45, Col 7 line 6-20), the kink detection system comprising: a fluid receiving portion configured to receive fluid from the medical delivery pump (Col 8 lines 28-Col 9 line 32 and Figs 3-4 which shows the detector positioned on the flow path-210); a diaphragm (diaphragm-220) coupled to the fluid receiving portion, the diaphragm configured to deform in correspondence with a change in pressure in the fluid received (Col 8 line 28-Col 9 line 32); a sensor (Sensor-230) configured to measure an extent of deformation of the diaphragm (Col 8 line 44-Col 9 line 16); one or more hardware processors (processors-50) and output an alert to the patient if the change passes the threshold (Col 9 line 23-32 and Col 9 line 63-Col 10 line 19); and a fluid outlet (exit port-70) configured to deliver the fluid to the patient. However, Flaherty fails to disclose one or more hardware processors configured to: determine a pressure in the fluid based on the extent of deformation ; determine if a change in the pressure in the fluid passes a threshold change; output an alert to the patient if the change in pressure passes the threshold. Olsen discloses one or more hardware processors (Control module-46 includes processor module-50) configured to: determine a pressure in the fluid based on the extent of deformation (Col 5 line 51-Col 6 line 9) ; determine if a change in the pressure in the fluid passes a threshold change (Col 7 line 43-Col 8 line 31); output an alert to the patient if the change in pressure passes the threshold (Col 8 line 13-16, Col 10 line 33-Col 12 line 63 discloses outputting an alert based on a pressure passing a threshold). It would have been obvious to one of ordinary skill in the art before the effective filing date to include Olsen into Flaherty for the purpose of increasing the life of the device. The modification would allow for shutting down or adjusting the device if undesired pressure is detected which protects the device from potential repair or replacement. Regarding claim 2, Flaherty discloses the disease management device according to claim 1. However, Flaherty fails to disclose the sensor comprises a capacitive sensor. Olsen discloses the sensor comprises a capacitive sensor. (Col 5 line 51-Col 6 line 9) It would have been obvious to one of ordinary skill in the art before the effective filing date to include Olsen into Flaherty for the purpose of increasing detection accuracy. The modification would allow for using sensors with a higher detection sensitivity which would increase measurement accuracy. Regarding claim 3, Flaherty in view of Olsen discloses the device according to claim 1. Furthermore, Flaherty discloses the sensor comprises a conductive sensor. (Col 8 line 65-Col 9 line 16) Regarding claim 6, Flaherty in view of Olsen discloses the device according to claim 3. Furthermore, Flaherty discloses the conductive sensor is located within a conductive sensing circuit (open circuit-230), the conductive sensing circuit comprising: a bias resistor (leads-232, 234); a conductive strip (conductive coating-236 on surface-224); and a controller (controller-50). (Col 9 17-32) Regarding claim 7, Flaherty in view of Olsen discloses the device according to claim 6. Furthermore, Flaherty discloses the conductive strip (coating-236 on surface-224) is configured to stretch as the pressure in the fluid is increased. (Col 9 line 6-16) Regarding claim 8, Flaherty in view of Olsen discloses the device according to claim 1. Furthermore, Flaherty discloses the one or more hardware processors (processor-50) are further configured to communicate with peripheral devices via Bluetooth (wireless receiver-60 communicates with remote device-100 using antenna-130). (Col 5 line 62-Col 6 line 9, Col 6 line 51-62) Regarding claim 9, Flaherty discloses a detection system (fluid delivery device-10 connected to device-100) configured to detect an obstruction within a fluid flow path (flow path-210 connected to exit port-70), the detection system comprising: a fluid receiving portion configured to receive fluid from a delivery pump (dispensers-40 can be a pump device, Col 8 line 4-27), (Col 8 lines 28-Col 9 line 32 and Figs 3-4 which shows the detector positioned on the flow path-210); a diaphragm (diaphragm-220) coupled to the fluid receiving portion, the diaphragm configured to deform in correspondence with a change in pressure in the fluid received (Col 8 line 28-Col 9 line 32); a sensor (sensor-230) configured to measure an extent of deformation of the diaphragm (Col 8 line 44-Col 9 line 16); and one or more hardware processors (processors-50) configured to output an alert to a user if the change in pressure passes the predetermined threshold (Col 9 line 23-32 and Col 9 line 63-Col 10 line 19). However, Flaherty fails to disclose determine a pressure in the fluid based on the extent of deformation; determine if a change in the pressure in the fluid passes a predetermined pressure threshold. Olsen discloses determine a pressure in the fluid based on the extent of deformation (Col 5 line 51-Col 6 line 9); determine if a change in the pressure in the fluid passes a predetermined pressure threshold (Col 7 line 43-Col 8 line 31). (Col 8 line 13-16, Col 10 line 33-Col 12 line 63 discloses outputting an alert based on a pressure passing a threshold). It would have been obvious to one of ordinary skill in the art before the effective filing date to include Olsen into Flaherty for the purpose of increasing the life of the device. The modification would allow for shutting down or adjusting the device if undesired pressure is detected which protects the device from potential repair or replacement. Regarding claim 10, Flaherty discloses the detection system according to claim 9. However, Flaherty fails to disclose the sensor comprises a capacitive sensor. Olsen discloses the sensor comprises a capacitive sensor. (Col 5 line 51-Col 6 line 9) It would have been obvious to one of ordinary skill in the art before the effective filing date to include Olsen into Flaherty for the purpose of increasing detection accuracy. The modification would allow for using sensors with a higher detection sensitivity which would increase measurement accuracy. Regarding claim 11, Flaherty in view of Olsen discloses the detection system according to claim 9. Furthermore, Flaherty discloses the sensor comprises a conductive sensor. (Col 8 line 65-Col 9 line 16) Regarding claim 12, Flaherty discloses a method (Abstract, claim 3, device-10 implements the method) of detecting a kink (flow condition sensor assembly-200 detects an occlusion/kink) within a disease management device (Col 5 line 46-61), the method comprising: passing fluid from a fluid source (reservoir-30) to a pump (dispenser-40 can be a pumping device, Col 8 line 4-27) through a fluid flow path within the disease management device; passing fluid from the pump to a kink detector (flow condition sensor assembly-200) through the fluid flow path (flow path-210); sensing movement of a diaphragm connected to the kink detector in response to the fluid passing (sensor-230); and passing fluid from the kink detector to a cannula (exit port-70 includes a cannula) located at an implantation site of a patient. (Fig 1, Col 7 line 32-60) However, Flaherty fails to disclose measuring pressure of the fluid based on movement of the diaphragm; determining if a kink is present within the fluid flow path based on the pressure of the fluid exceeding a predetermined pressure threshold. Olsen discloses measuring pressure of the fluid based on movement of the diaphragm (Col 5 line 51-Col 6 line 9); determining if a kink is present within the fluid flow path based on the pressure of the fluid exceeding a predetermined pressure threshold (Col 8 line 13-16, Col 10 line 33-Col 12 line 63). It would have been obvious to one of ordinary skill in the art before the effective filing date to include Olsen into Flaherty for the purpose of increasing the life of the device. The modification would allow for shutting down or adjusting the device if undesired pressure is detected which protects the device from potential repair or replacement. Regarding claim 13, Flaherty in view of Olsen discloses the method according to claim 12. Furthermore, Flaherty discloses alerting a patient of the kink based on a determination of a kink presence. (Col 9 line 23-32 and Col 8 line 63-Col 10 line 19) Regarding claim 14, Flaherty discloses the method according to claim 12. However, Flaherty fails to disclose a capacitive sensor senses movement of the diaphragm. Olsen discloses a capacitive sensor senses movement of the diaphragm. (Col 5 line 51-Col 6 line 9) It would have been obvious to one of ordinary skill in the art before the effective filing date to include Olsen into Flaherty for the purpose of increasing detection accuracy. The modification would allow for using sensors with a higher detection sensitivity which would increase measurement accuracy. Regarding claim 15, Flaherty in view of Olsen discloses the method according to claim 12. Furthermore, Flaherty discloses a conductive sensor senses movement of the diaphragm. (Col 8 line 65-Col 9 line 16) Regarding claim 16, Flaherty in view of Olsen discloses the method according to claim 15. Furthermore, Flaherty discloses the conductive sensor is located within a conductive sensing circuit (open circuit-230) comprising: a conductive strip (conductive coating-238 on surface-224) configured to measure a force of the diaphragm; a bias resistor (leads-232, 234); and a controller (Controller-50). (Col 9 line 17-32) Regarding claim 17, Flaherty in view of Olsen discloses the method according to claim 16. Furthermore, Flaherty discloses the conductive strip (coating-236 on surface-224) is configured to stretch as the pressure in the fluid is increased. (Col 9 line 6-16) Regarding claim 22, Flaherty discloses a disease management device (fluid delivery device-10) comprising: a medical delivery pump (dispensers-40 can be a pump device, Col 8 line 4-27) configured to deliver a flow of medication (reservoir-30) to a patient (Exit port-70, Col 5 line 46-61); and a kink detection system (flow condition assembly-200) having a sensor (sensors-230), the kink detection system configured to indicate an increase in pressure in the flow or a lack of the flow when the flow is expected (Col 5 line 37-45, Col 7 line 11-20), the kink detection system further comprising: a fluid receiving portion () configured to receive fluid from the medical delivery pump (Col 8 lines 28-Col 9 line 32 and Figs 3-4 which shows the detector positioned on the flow path-210); a diaphragm (diaphragm-220) coupled to the fluid receiving portion, the diaphragm configured to deform corresponding to a change in pressure in the fluid received (Col 8 line 28-Col 9 line 32); a sensor (sensors-230) configured to measure an extent of deformation of the diaphragm; one or more hardware processors (processors-50) configured to: determine a pressure in the fluid based on the extent of deformation (Col 8 line 44-Col 9 line 16); and output an alert to the patient if the change passes the threshold change (Col 9 line 23-32 and Col 9 line 63-Col 10 line 19); and a fluid outlet (exit port-70) configured to deliver the fluid to the patient. However, Flaherty discloses determine if a change in the pressure in the fluid passes a threshold change; and output an alert to the patient if the change in pressure passes the threshold change. Olsen discloses determine if a change in the pressure in the fluid passes a threshold change (Col 7 line 43-Col 8 line 31); and output an alert to the patient if the change in pressure passes the threshold change. (Col 8 line 13-16, Col 10 line 33-Col 12 line 63 discloses outputting an alert based on a pressure passing a threshold). It would have been obvious to one of ordinary skill in the art before the effective filing date to include Olsen into Flaherty for the purpose of increasing the life of the device. The modification would allow for shutting down or adjusting the device if undesired pressure is detected which protects the device from potential repair or replacement. Claims 4-5 and 18-20 are rejected under 35 U.S.C. 103 as being unpatentable over Flaherty US7887505 in view of Olsen US5935106 in further view of Haase 6700392. Regarding claim 4, the combination of Flaherty in view of Olsen disclose the device according to claim 2. However, the combination fails to disclose the capacitive sensor is located within a capacitive sensing circuit, the capacitive sensing circuit comprising: a bias resistor; a touchpad; a capacitor; and a controller. Haase discloses the capacitive sensor (sensing capacitor-310) is located within a capacitive sensing circuit (circuit-100), the capacitive sensing circuit comprising: a bias resistor (resistor-312); a touchpad (capacitor-310); a capacitor (Schmitt trigger-110, 309); and a controller (counter/timer module, Col 9 line 27-37). (Fig 1 and 3) It would have been obvious to one of ordinary skill in the art before the effective filing date to include Haase into Flaherty for the purpose of increasing detection accuracy. The modification would allow for using sensors with a higher detection sensitivity which would increase measurement accuracy. Regarding claim 5, the combination of Flaherty in view of Olsen disclose the device according to claim 4. However, the combination fails to disclose an electrical capacitance of the touchpad (capacitor-310) is configured to correspond to movement of the diaphragm. (Col 6 line 5-Col 7 line 10) It would have been obvious to one of ordinary skill in the art before the effective filing date to include Haase into Flaherty for the purpose of increasing detection accuracy. The modification would allow for using sensors with a higher detection sensitivity which would increase measurement accuracy. Regarding claim 18, the combination of Flaherty in view of Olsen disclose the method according to claim 14. However, the combination fails to disclose the capacitive sensor is located within a capacitive sensing circuit comprising: a bias resistor; a touchpad; a capacitor; and a controller. Haase discloses the capacitive sensor (sensing capacitor-310) is located within a capacitive sensing circuit (circuit-100) comprising: a bias resistor (resistor-312); a touchpad (capacitor-310); a capacitor (Schmitt trigger-110, 309); and a controller (counter/timer module, Col 9 line 27-37). (Fig 1 and 3) It would have been obvious to one of ordinary skill in the art before the effective filing date to include Haase into Flaherty for the purpose of increasing detection accuracy. The modification would allow for using sensors with a higher detection sensitivity which would increase measurement accuracy. Regarding claim 19, the combination of Flaherty in view of Olsen disclose the method according to claim 18. However, the combination fails to disclose the capacitor measures an electrical capacitance of the touchpad. Haase discloses the capacitor (Schmitt treigger-110, 309) measures an electrical capacitance of the touchpad (capacitor-310). It would have been obvious to one of ordinary skill in the art before the effective filing date to include Haase into Flaherty for the purpose of increasing detection accuracy. The modification would allow for using sensors with a higher detection sensitivity which would increase measurement accuracy. Regarding claim 20, the combination of Flaherty in view of Olsen disclose the method according to claim 19. However, the combination fails to disclose the electrical capacitance is configured to correspond to the movement of the diaphragm. Haase discloses the electrical capacitance is configured to correspond to the movement of the diaphragm. (Col 6 line 5-Col 7 line 10) It would have been obvious to one of ordinary skill in the art before the effective filing date to include Haase into Flaherty for the purpose of increasing detection accuracy. The modification would allow for using sensors with a higher detection sensitivity which would increase measurement accuracy. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 21 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Flaherty US7887505. Regarding claim 21, Flaherty discloses a method (Abstract, claim 3, device-10 implements the method) of detecting a kink (flow condition sensor assembly-200 detects an occlusion/kink) within a medication delivery system (Col 5 line 46-61), the method comprising: passing fluid from a fluid source (reservoir-30) to a pump (dispenser-40 can be a pumping device, Col 8 line 4-27) through a fluid flow path (flow path-210) within the medication delivery system; passing fluid from the pump to a kink detector (assembly-200) through the fluid flow path; and sensing (sensor-230), based on deformation of a diaphragm (diaphragm-220) coupled to the fluid flow path, an increase in pressure in the fluid or a lack of a flow of fluid when the flow is expected (Col 5 line 37-45, Col 7 line 11-20). Conclusion The prior art as cited on the PTO-892 is made of record and not relied upon but considered pertinent to applicant's disclosure. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NIGEL H PLUMB whose telephone number is (571)272-8886. The examiner can normally be reached Monday-Friday 7am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, John Breene can be reached at 571-272-4107. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (USA or CANADA) or 571-272-1000. /NIGEL H PLUMB/Examiner, Art Unit 2855 /Eric S. McCall/Primary Examiner, Art Unit 2855
Read full office action

Prosecution Timeline

Aug 04, 2022
Application Filed
Aug 27, 2025
Non-Final Rejection mailed — §102, §103, §112
Nov 26, 2025
Response Filed
Jan 14, 2026
Final Rejection mailed — §102, §103, §112
Feb 24, 2026
Response after Non-Final Action
Apr 08, 2026
Request for Continued Examination
Apr 16, 2026
Response after Non-Final Action
Apr 29, 2026
Non-Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12638354
COMBINATION PRESSURE AND TEMPERATURE SENSOR
2y 8m to grant Granted May 26, 2026
Patent 12638583
FLEXIBLE ULTRASOUND ARRAY FOR MEASURING A CURVED OBJECT WITH SCATTERING ELEMENT
2y 3m to grant Granted May 26, 2026
Patent 12631660
RECIRCULATION OF A SAMPLE FLUID FOR ANALYSIS IN A MICROFLUIDIC DEVICE
3y 5m to grant Granted May 19, 2026
Patent 12631510
PRESSURE SENSOR MANIFOLDS FOR HIGH TEMPERATURES
2y 8m to grant Granted May 19, 2026
Patent 12631504
SENSOR MEMBER
2y 9m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
91%
Grant Probability
92%
With Interview (+1.2%)
2y 1m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 679 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month